1. Mol Genet Genomic Med. 2021 Jun;9(6):e1692. doi: 10.1002/mgg3.1692. Epub 2021 
May 7.

Progressive cerebellar atrophy in a patient with complex II and III deficiency 
and a novel deleterious variant in SDHA: A Counseling Conundrum.

Sturrock BRH(1)(2), Macnamara EF(1), McGuire P(3), Kruk S(3), Yang I(3), Murphy 
J(1); Undiagnosed Diseases Network(4); Tifft CJ(1)(5), Gordon-Lipkin E(3).

Collaborators: Acosta MT, Adam M, Adams DR, Agrawal PB, Alejandro ME, Alvey J, 
Amendola L, Andrews A, Ashley EA, Azamian MS, Bacino CA, Bademci G, Baker E, 
Balasubramanyam A, Baldridge D, Bale J, Bamshad M, Barbouth D, Bayrak-Toydemir 
P, Beck A, Beggs AH, Behrens E, Bejerano G, Bennet J, Berg-Rood B, Bernstein JA, 
Berry GT, Bican A, Bivona S, Blue E, Bohnsack J, Bonnenmann C, Bonner D, Botto 
L, Boyd B, Briere LC, Brokamp E, Brown G, Burke EA, Burrage LC, Butte MJ, Byers 
P, Byrd WE, Carey J, Carrasquillo O, Chang TCP, Chanprasert S, Chao HT, Clark 
GD, Coakley TR, Cobban LA, Cogan JD, Coggins M, Sessions Cole F, Colley HA, 
Cooper CM, Cope H, Craigen WJ, Crouse AB, Cunningham M, D'Souza P, Dai H, Dasari 
S, Davids M, Dayal JG, Deardorff M, Dell'Angelica EC, Dhar SU, Dipple K, Doherty 
D, Dorrani N, Douine ED, Draper DD, Duncan L, Earl D, Eckstein DJ, Emrick LT, 
Eng CM, Esteves C, Estwick T, Falk M, Fernandez L, Ferreira C, Fieg EL, Findley 
LC, Fisher PG, Fogel BL, Forghani I, Fresard L, Gahl WA, Glass I, Godfrey RA, 
Golden-Grant K, Goldman AM, Goldstein DB, Grajewski A, Groden CA, Gropman AL, 
Gutierrez I, Hahn S, Hamid R, Hanchard NA, Hassey K, Hayes N, High F, Hing A, 
Hisama FM, Holm IA, Hom J, Horike-Pyne M, Huang A, Huang Y, Isasi R, Jamal F, 
Jarvik GP, Jarvik J, Jayadev S, Johnston JM, Karaviti L, Kelley EG, Kennedy J, 
Kiley D, Kohane IS, Kohler JN, Krakow D, Krasnewich DM, Kravets E, Korrick S, 
Koziura M, Krier JB, Lalani SR, Lam B, Lam C, Lanpher BC, Lanza IR, Lau CC, 
LeBlanc K, Lee BH, Lee H, Levitt R, Lewis RA, Lincoln SA, Liu P, Liu XZ, Longo 
N, Loo SK, Loscalzo J, Maas RL, Macnamara EF, MacRae CA, Maduro VV, Majcherska 
MM, Mak B, Malicdan MCV, Mamounas LA, Manolio TA, Mao R, Maravilla K, Markello 
TC, Marom R, Marth G, Martin BA, Martin MG, Martínez-Agosto JA, Marwaha S, 
McCauley J, McConkie-Rosell A, McCormack CE, McCray AT, McGee E, Mefford H, 
Merritt JL, Might M, Mirzaa G, Morava E, Moretti PM, Morimoto M, Mulvihill JJ, 
Murdock DR, Nakano-Okuno M, Nath A, Nelson SF, Newman JH, Nicholas SK, Nickerson 
D, Nieves-Rodriguez S, Novacic D, Oglesbee D, Orengo JP, Pace L, Pak S, Pallais 
JC, Palmer CGS, Papp JC, Parker NH, Phillips JA 3rd, Posey JE, Potocki L, Pusey 
BN, Quinlan A, Raskind W, Raja AN, Rao DA, Renteria G, Reuter CM, Rives L, 
Robertson AK, Rodan LH, Rosenfeld JA, Rosenwasser N, Ruzhnikov M, Sacco R, 
Sampson JB, Samson SL, Saporta M, Scott CR, Schaechter J, Schedl T, Schoch K, 
Scott DA, Sharma P, Shashi V, Shin J, Signer R, Sillari CH, Silverman EK, 
Sinsheimer JS, Sisco K, Smith EC, Smith KS, Solem E, Solnica-Krezel L, Spillmann 
RC, Stoler JM, Stong N, Sullivan JA, Sullivan K, Sun A, Sutton S, Sweetser DA, 
Sybert V, Tabor HK, Tamburro CP, Tan QK, Tekin M, Telischi F, Thorson W, Tifft 
CJ, Toro C, Tran AA, Tucker BM, Urv TK, Vanderver A, Velinder M, Viskochil D, 
Vogel TP, Wahl CE, Wallace S, Walley NM, Walsh CA, Walker M, Wambach J, Wan J, 
Wang LK, Wangler MF, Ward PA, Wegner D, Wener M, Wenger T, Perry KW, Westerfield 
M, Wheeler MT, Whitlock J, Wolfe LA, Woods JD, Yamamoto S, Yang J, Yu G, Zastrow 
DB, Zhao C, Zuchner S.

Author information:
(1)National Institutes of Health Undiagnosed Diseases Program, Common Fund, 
Office of the Director, NIH, Bethesda, MD, USA.
(2)Brighton and Sussex University Hospitals NHS Trust, Brighton, England.
(3)Metabolism, Infection and Immunity Section, National Human Genome Research 
Institute, NIH, Bethesda, MD, USA.
(4)Common Fund, Office of the Director, NIH, Bethesda, MD, USA.
(5)Office of the Clinical Director, National Human Genome Research Institute, 
NIH, Bethesda, MD, USA.

BACKGROUND: Complex II is an essential component of the electron transport 
chain, linking it with the tricarboxylic acid cycle. Its four subunits are 
encoded in the nuclear genome, and deleterious variants in these genes, 
including SDHA (OMIM 600857), are associated with a wide range of symptoms 
including neurological disease, cardiomyopathy, and neoplasia 
(paraganglioma-pheochromocytomas (PGL/PCC), and gastrointestinal stromal 
tumors). Deleterious variants of SDHA are most frequently associated with Leigh 
and Leigh-like syndromes.
METHODS AND RESULTS: Here, we describe a case of a 9-year-old boy with tremor, 
nystagmus, hypotonia, developmental delay, significant ataxia, and progressive 
cerebellar atrophy. He was found to have biallelic variants in SDHA, a known 
pathogenic variant (c.91C>T (p.R31*)), and a variant of unknown significance 
(c.454G>A (p.E152K)). Deficient activity of complexes II and III was detected in 
fibroblasts from the patient consistent with a diagnosis of a respiratory chain 
disorder.
CONCLUSION: We, therefore, consider whether c.454G>A (p.E152K) is, indeed, a 
pathogenic variant, and what implications it has for family members who carry 
the same variant.

© 2021 The Authors. Molecular Genetics & Genomic Medicine published by Wiley 
Periodicals LLC.

DOI: 10.1002/mgg3.1692
PMCID: PMC8222855
PMID: 33960148 [Indexed for MEDLINE]

Conflict of interest statement: The authors have declares no conflicts of 
interest.